2009
DOI: 10.1038/461027a
|View full text |Cite
|
Sign up to set email alerts
|

GM crops: Battlefield

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
32
0
2

Year Published

2010
2010
2018
2018

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(34 citation statements)
references
References 15 publications
0
32
0
2
Order By: Relevance
“…Recently, Bt-maize and particularly MON810 maize were the focus of scientific controversy in the United States (U.S. Environmental Protection Agency [EPA], 2010, pp. 67-68;Waltz, 2009), while in Europe, despite a European approval for cultivation of MON810 maize, controversial temporary prohibitions on cultivation were implemented in Austria, France, Germany, Greece, Luxemburg, and Hungary, based upon what these countries noted as scientific evidence of risk of adverse effects to biodiversity (Bøhn et al, 2012;Wickson et al, 2013). Within both science and policy settings, evidential basis for evaluating the potential risk of adverse effects from MON810 maize to nontarget organisms and biodiversity remains a topic of ongoing debate (Bøhn et al, 2012;Ricroch et al, 2010;Romeis et al, 2013;Wickson et al, 2013).…”
mentioning
confidence: 99%
“…Recently, Bt-maize and particularly MON810 maize were the focus of scientific controversy in the United States (U.S. Environmental Protection Agency [EPA], 2010, pp. 67-68;Waltz, 2009), while in Europe, despite a European approval for cultivation of MON810 maize, controversial temporary prohibitions on cultivation were implemented in Austria, France, Germany, Greece, Luxemburg, and Hungary, based upon what these countries noted as scientific evidence of risk of adverse effects to biodiversity (Bøhn et al, 2012;Wickson et al, 2013). Within both science and policy settings, evidential basis for evaluating the potential risk of adverse effects from MON810 maize to nontarget organisms and biodiversity remains a topic of ongoing debate (Bøhn et al, 2012;Ricroch et al, 2010;Romeis et al, 2013;Wickson et al, 2013).…”
mentioning
confidence: 99%
“…Cette étude, cosignée par de nombreux penses, qu'il serait très audacieux ou mal vu de contester 7 . Inversement, les chercheurs qui critiquent la qualité, les résultats ou les produits issus de recherches financées par les grandes compagnies pharmaceutiques, chimiques ou industrielles prennent le risque de voir leur carrière attaquée, comme ce fut le cas pour la docteure Nancy Olivieri (j'y reviendrai) ou la biologiste Emma Rosi-Marshall (Waltz, 2009), et leur professionnalisme démoli, ce que vit actuellement le biologiste moléculaire Gilles-Éric Séralini à la suite de son étude contestant la capacité des données fournies par Monsanto de démontrer formellement l'innocuité de trois maïs transgéniques (Comité de recherche et d'information indépendantes sur le génie génétique, 2010). Est-il encore possible pour les chercheurs de mener sereinement des débats scientifiques, nécessaires à toute avancée de la science, dans un contexte de plus en plus dominé par des enjeux financiers ?…”
Section: Florence Piron Université Lavalunclassified
“…While GMO and the science supporting it have been controversial (Devos et al, 2008;Waltz, 2009;Bawa & Anilakumar, 2013), genetic modification has provided pest, herbicide and drought resilient crop varieties (Morris, 2011;Vencill et al, 2012). Although only on the cusp of commercial availability, genetically modified laboratory science has enhanced the genetic improvement of livestock with an aim to further increasing productive output, taste and resistance to disease (Wheeler et al, 2003;McColl et al, 2013;Laible et al, 2015).…”
Section: Industrial Agriculturementioning
confidence: 99%